|
by By E. Christian Brugger, D. Phil, Senior Fellow in Ethics
|
|
WASHINGTON, D.C., AUG. 25, 2010 (Zenit.org).- On Aug. 13, the U.S. Food
and Drug Administration (FDA) announced the approval of a new "emergency
contraceptive" called "Ella." Its competitor, Plan B, is said to
"prevent pregnancy" up to 72 hours (3 days) after intercourse. Ella
boasts of 120 hours (5 days) of post-coital effectiveness. The drug is
produced by the Paris-based pharmaceutical company HRA Pharma and will
be marketed by Watson Pharmaceuticals based out of Morristown, New
Jersey. The FDA advisors voted unanimously to approve the drug.
|
|
Read more...
|
|
08/26/2010
|